114 related articles for article (PubMed ID: 23746953)
21. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
[TBL] [Abstract][Full Text] [Related]
22. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice.
Hitt A; Graves E; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):56-66. PubMed ID: 15625704
[TBL] [Abstract][Full Text] [Related]
23. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice.
Adams V; Mangner N; Gasch A; Krohne C; Gielen S; Hirner S; Thierse HJ; Witt CC; Linke A; Schuler G; Labeit S
J Mol Biol; 2008 Dec; 384(1):48-59. PubMed ID: 18804115
[TBL] [Abstract][Full Text] [Related]
24. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
25. Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma.
Lin XY; Chen SZ
Oncol Rep; 2017 Mar; 37(3):1601-1610. PubMed ID: 28112357
[TBL] [Abstract][Full Text] [Related]
26. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
27. The study on mechanism of the modified Chinese herbal compound, jianpijiedu, on a mouse model of hepatic carcinoma cachexia.
Sun B; Luo H; Deng L; Zhang S; Chen Z
Mol Med Rep; 2016 Oct; 14(4):3113-21. PubMed ID: 27511050
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
[TBL] [Abstract][Full Text] [Related]
29. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
[TBL] [Abstract][Full Text] [Related]
30. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments.
Hatakeyama S; Summermatter S; Jourdain M; Melly S; Minetti GC; Lach-Trifilieff E
Skelet Muscle; 2016; 6():26. PubMed ID: 27462398
[TBL] [Abstract][Full Text] [Related]
31. c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice.
Tian M; Kliewer KL; Asp ML; Stout MB; Belury MA
Mol Nutr Food Res; 2011 Feb; 55(2):268-77. PubMed ID: 20827675
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice.
Zhao ZJ; Xiang JY; Liu L; Huang XL; Gan HT
Int Immunopharmacol; 2012 Jan; 12(1):169-74. PubMed ID: 22155740
[TBL] [Abstract][Full Text] [Related]
34. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
Sugiyama M; Yamaki A; Furuya M; Inomata N; Minamitake Y; Ohsuye K; Kangawa K
Regul Pept; 2012 Oct; 178(1-3):21-8. PubMed ID: 22750276
[TBL] [Abstract][Full Text] [Related]
35. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Granado M; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
[TBL] [Abstract][Full Text] [Related]
36. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
Granado M; Martín AI; Priego T; López-Calderón A; Villanúa MA
J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
39. Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats.
Tanada Y; Shioi T; Kato T; Kawamoto A; Okuda J; Kimura T
Life Sci; 2015 Sep; 137():20-7. PubMed ID: 26141987
[TBL] [Abstract][Full Text] [Related]
40. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
